U.S. Pharma Stock News

GE HealthCare Technologies (NasdaqGS:GEHC) received FDA clearance for three MRI systems and AI workflow tools, marking a new phase for its imaging portfolio. The company expanded its collaboration with BARDA to speed up AI-powered ultrasound solutions for trauma and emergency use. GE HealthCare also entered a commercial partnership with Gentuity to increase access to advanced cardiac imaging technologies in the U.S. GE HealthCare sits at the intersection of medical imaging, diagnostics, and...

Earlier this week, OLAPLEX Holdings, Inc. launched No.3PLUS Complete Repair Treatment, a three-minute pre-shampoo product using its patented Bond Building Technology™ and new Damage Defense Cationic Complex, supported by a “Science Never Looked So Good” campaign featuring Chloe Fineman and broad distribution across major retail and online channels. This new treatment extends OLAPLEX’s core bond-repair franchise into a faster, more convenient format, aiming to reinforce its science-led brand...

Macy's (NYSE:M) is laying off staff in New Jersey and reshaping key departments including fragrances and jewelry as part of a broad restructuring. The company has sold its Triangle Town Center store, changing its physical store footprint in that market. Macy's is launching a year long "Celebrations Start at Macy’s" customer engagement platform aimed at keeping shoppers connected across seasons and events. Macy's (NYSE:M), trading at $19.78, sits at an interesting point for investors...

Syndax Pharmaceuticals (SNDX) just closed out FY 2025 with Q4 revenue of US$68.7 million and a basic EPS loss of US$0.78. Trailing twelve month revenue was US$172.4 million, and basic EPS over that period was a loss of US$3.29. The company’s quarterly revenue moved from US$7.7 million in Q4 2024 to US$68.7 million in Q4 2025. Over the same stretch, quarterly basic EPS losses ranged from US$1.10 to US$0.70 to US$0.98. This keeps the focus squarely on how efficiently that revenue is being...

Why Landstar System Stock Is Back in Focus Landstar System (LSTR) has put out its 2025 10-K, flagging lower revenue and net income tied to softer freight demand and higher insurance costs. The filing also details buybacks, dividends, and a planned sale of its Mexican subsidiary. See our latest analysis for Landstar System. The 10-K arrives after a strong run in the shares, with the 90-day share price return of 24.54% far outpacing the 5.25% total shareholder return over the past year. This...

Apple (NasdaqGS:AAPL) plans a major U.S. manufacturing expansion, including Mac mini and AI server production at its Houston facility. The company has outlined a US$600b supply chain investment and related workforce and upskilling efforts in the United States. Apple is developing AI focused hardware such as smart glasses and camera equipped AirPods as part of a broader hardware push. Apple Pay is expected to launch in India by mid 2026 with local bank partnerships and UPI integration. For...

In recent weeks, Alaska Air Group secured a single operating certificate for Alaska Airlines and Hawaiian Airlines, while analysts highlighted its stronger-than-expected earnings, improved cost control, and operational discipline. This combination of operational progress and favorable analyst commentary has supported a more constructive view of Alaska Air Group’s earnings potential and business resilience, even as the airline industry remains cyclical and exposed to cost and demand...

Illumina (NasdaqGS:ILMN) has launched TruPath Genome, a whole genome offering focused on higher accuracy, efficiency, and resolving complex genomic regions. The company is partnering with Florida State University's pediatric rare disease lab to provide clinical sequencing services for children with suspected rare conditions. Together, these moves expand Illumina's presence in rare disease diagnostics and applied clinical genomics. For investors watching genomics, Illumina remains a central...

Renewed takeover speculation around CRISPR Therapeutics (NasdaqGM:CRSP) has intensified, with Vertex Pharmaceuticals cited in recent M&A blog coverage as a potential acquirer. Commentary also points to reported legal advisement engagements, suggesting active consideration of transaction options. The rumors have drawn fresh attention from both market participants and industry observers, putting potential corporate actions in sharper focus. CRISPR Therapeutics, focused on gene editing...

On February 25, 2026, The Bancorp Inc filed its annual 10-K report, outlining its focus on fintech solutions, specialty lending, and technology and AI investments to support its banking operations. The filing revealed that 91% of Bancorp’s total deposits come from its Fintech Solutions segment, underscoring both its concentration risk and its differentiated position as a fintech-focused bank. We’ll now examine how Bancorp’s heavy reliance on fintech-derived deposits, as detailed in the 10-K,...

Western Alliance Bancorporation recently filed its 2025 Form 10-K, detailing brand consolidation under Western Alliance Bank, capital actions in subordinated and preferred securities, and an ongoing emphasis on asset quality, deposit growth, and digital banking capabilities. These company initiatives have unfolded alongside broader market pressure tied to higher-than-expected inflation and shifting Federal Reserve rate expectations, which have amplified volatility for Western Alliance...

PDF Solutions (PDFS) is back on radar after the Brown Capital Management Small Company Fund added the stock in Q4 2025, citing its AI-focused analytics and semiconductor supply chain solutions as key attractions. See our latest analysis for PDF Solutions. At a share price of US$33.78, PDF Solutions has seen a 24.65% 90 day share price return and a 50.00% 1 year total shareholder return, suggesting momentum has picked up as investors respond to its AI and semiconductor supply chain story. If...

Cisco Systems (NasdaqGS:CSCO) has released an enterprise software product built entirely with AI generated code. The company plans to have at least six AI written products in its portfolio by the end of 2026. Cisco is pairing this AI push with a focus on safety and security standards across its new offerings. Cisco sits at the intersection of networking hardware, security and enterprise software, so a move to AI written products touches several of its core businesses. For investors watching...

What the recent share performance says about Green Brick Partners Green Brick Partners (GRBK) has seen mixed recent returns, with a 5.2% decline over the past day and 6.4% over the past week, while the stock is higher over the past month and past 3 months. See our latest analysis for Green Brick Partners. That recent 5.2% one-day share price decline and 6.4% 7-day share price pullback come after a 6.2% 1-month and 8.5% 3-month share price return, alongside a 16.5% year-to-date share price...

Paramount Skydance, NasdaqGS:PSKY, has agreed to acquire Warner Bros. Discovery in a cash and stock deal valued at $110b. The transaction follows a competitive bidding process that included Netflix and will fold assets such as CNN into the combined group. The company has outlined plans for broad cost savings and operational efficiencies across studios, streaming platforms and news operations. For investors watching NasdaqGS:PSKY, the deal comes against a backdrop of mixed long term share...

Twist Bioscience (TWST) is back in focus after announcing a licensing deal with Invenra that brings the B-Body bispecific antibody platform under a co-exclusive arrangement, directly expanding Twist’s antibody discovery service offering. See our latest analysis for Twist Bioscience. The licensing news lands after a strong run, with the latest share price at $46.92, a 30 day share price return of 11.69% and a 90 day share price return of 46.58%. Looking further out, the stock shows a 1 year...

In late February 2026, Diamondback Energy reported a very large US$3.65 billion impairment, a fourth-quarter 2025 net loss, and updated 2026 production guidance alongside a higher base dividend and continued buybacks. The company paired this accounting hit with strong capital returns and an expanded Barnett Shale program, signaling an emphasis on long-term resource depth and shareholder payouts despite near-term earnings pressure. We’ll now examine how the Barnett Shale expansion and...

If you are wondering whether Palvella Therapeutics at around US$135 is still offering value after a strong run, this article focuses squarely on what the current price might be implying. The stock has moved sharply recently, with a 57.6% return over the last 7 days, 71.5% over 30 days, and 34.6% year to date, while the 1 year return is very large at close to 7x. These moves sit against a backdrop of heightened interest in Palvella Therapeutics, including investor attention around its listing...

In February 2026, Hess Midstream LP filed an omnibus shelf registration covering Class A common shares and preferred stock, giving it the ability to issue new equity securities over time. This filing expands the company’s financial flexibility, potentially supporting future projects, balance sheet goals, or ownership changes that could matter for longer-term investors. We’ll now look at how this expanded financing flexibility might influence Hess Midstream’s existing investment narrative...

Global policymakers and investors are increasingly focused on the risk that Taiwan’s semiconductor exports could be disrupted, putting Taiwan Semiconductor Manufacturing (NYSE:TSM) at the center of the discussion. Concerns relate to how heavily the U.S. tech sector, including AI, cloud, consumer electronics, and defense contractors, depends on TSMC’s advanced chips produced in Taiwan. Recent commentary from governments and industry groups has highlighted efforts to reduce single region...

In late February 2026, Goldman Sachs Group faced mounting pressure as rising wholesale inflation, renewed concerns over private credit risks, and sector-wide worries about AI’s impact on banking coincided with extensive new bond issuance across fixed, floating, and step-up structures in US dollars and euros. This combination of macro stress and active balance sheet funding highlights how Goldman Sachs is simultaneously managing inflation-sensitive credit risk and securing diverse,...

If you are wondering whether SolarEdge Technologies' current share price reflects its true worth, this article will walk you through what the numbers are saying about value today. The stock closed at US$35.40 recently, with a 7 day return of a 6.6% decline, a 30 day return of a 1.1% decline, a 12.9% gain year to date and a 114.7% gain over the past year. These figures are set against much weaker 3 year and 5 year returns of an 89.2% decline and an 85.8% decline. Recent share price moves sit...

MaxLinear (NasdaqGS:MXL) plans to showcase its Sierra RAN radio platform with advanced PIM cancellation technology at MWC Barcelona 2026. The company aims to address deployment challenges for Mobile Network Operators by highlighting its RAN radio capabilities at the event. MaxLinear has appointed Kris Sennesael, an experienced semiconductor industry executive, to its Board of Directors and Audit Committee. MaxLinear focuses on radio access network and connectivity solutions, so the MWC...

PENN Entertainment (NasdaqGS:PENN) has ended a proxy battle with activist investor HG Vora through a cooperation agreement. As part of the deal, three new independent directors are joining the board and the board is being expanded. The governance changes follow PENN's exit from its ESPN Bet partnership and ongoing corporate restructuring efforts. PENN Entertainment, a major US regional casino and online gaming operator, is reworking its boardroom as it reorients around its core land based...